Solid-phase synthesis and pharmacological evaluation of analogues of PhTX-12-A potent and selective nicotinic acetylcholine receptor antagonist

Kristian Strømgaard, Ian R Mellor, Kim Andersen, Ioana Neagoe, Florentina Pluteanu, Peter N R Usherwood, Povl Krogsgaard-Larsen, Jerzy W Jaroszewski

    22 Citations (Scopus)

    Abstract

    Philanthotoxin-12 (PhTX-12) is a novel potent and selective, noncompetitive antagonist of nicotinic acetylcholine receptors (nAChRs). Homologues of PhTX-12 with 7-11 methylene groups between the primary amino group and the aromatic head-group were synthesized using solid-phase methodology. In vitro electrophysiological studies of nAChR demonstrated that decreasing the number of methylene groups from 12 to 11 significantly increased potency. Antagonism by PhTX-11, like that of PhTX-12, was only weakly voltage-dependent. When the methylene spacer was reduced further, antagonism was decreased below that of PhTX-12, and in some cases potentiation of ACh responses by up to 60% was observed.
    Original languageEnglish
    JournalBioorganic & Medicinal Chemistry Letters
    Volume12
    Issue number8
    Pages (from-to)1159-1162
    Number of pages4
    ISSN0960-894X
    Publication statusPublished - 22 Apr 2002

    Keywords

    • Chromatography, High Pressure Liquid
    • Drug Evaluation, Preclinical
    • Mass Spectrometry
    • Nicotinic Antagonists
    • Patch-Clamp Techniques
    • Polyamines
    • Tyrosine

    Fingerprint

    Dive into the research topics of 'Solid-phase synthesis and pharmacological evaluation of analogues of PhTX-12-A potent and selective nicotinic acetylcholine receptor antagonist'. Together they form a unique fingerprint.

    Cite this